In the realm of advanced organic chemistry and pharmaceutical synthesis, specific molecular structures serve as indispensable building blocks for complex drug molecules. Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate, cataloged under CAS number 61397-56-6, is one such critical intermediate. This article explores its synthesis pathways and highlights its pivotal applications, particularly in the development of antifungal pharmaceuticals. It aims to inform researchers and procurement specialists about the value and sourcing of this compound.

Understanding the Chemical Structure and Synthesis

Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate is characterized by its complex structure, which includes a dioxolane ring, a bromomethyl group, a 2,4-dichlorophenyl substituent, and a benzoate ester. This intricate arrangement of functional groups is precisely what makes it a valuable precursor in multi-step organic syntheses. While the detailed synthesis pathways can be proprietary, they typically involve chiral synthesis techniques to achieve the desired cis stereochemistry, which is crucial for the biological activity of the downstream products. Manufacturers focus on optimizing these routes to ensure high yields and purity, often starting from more basic chemical feedstocks.

The presence of the reactive bromomethyl group (-CH2Br) is key to its utility, allowing for nucleophilic substitution reactions. The 2,4-dichlorophenyl moiety contributes to the lipophilicity and receptor binding characteristics of the final drug molecule. For procurement managers, understanding that the synthesis requires specialized expertise and equipment underscores the importance of selecting a skilled and experienced manufacturer.

Key Applications in Pharmaceutical Manufacturing

The primary and most significant application of Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate (CAS 61397-56-6) is its role as a crucial intermediate in the synthesis of potent triazole antifungal agents. Two prominent examples are:

  • Ketoconazole: This broad-spectrum antifungal drug is widely prescribed for treating various fungal infections, including dermatophytosis and candidiasis. The intermediate provides a significant portion of the molecule's core structure.
  • Itraconazole: Another potent antifungal medication, Itraconazole, is used to treat a range of systemic fungal infections. The intermediate is essential for building its complex molecular architecture.

Beyond these established drugs, the unique chemical features of CAS 61397-56-6 also make it a valuable compound for research and development efforts aimed at discovering novel antifungal agents or other pharmaceuticals. Its structure can be a starting point for exploring new chemical entities with improved efficacy or expanded therapeutic profiles.

Sourcing and Purchasing Considerations

When you are looking to buy Cis-2-(Bromomethyl)-2-(2,4-Dichlorophenyl)-1,3-Dioxolane-4-Ylmethyl Benzoate, it is imperative to partner with a reliable manufacturer. Key considerations include:

  • Purity: Ensure the manufacturer can consistently supply material with a minimum purity of 98%.
  • Stereochemistry: Confirm that the cis isomer is produced to specification.
  • Regulatory Compliance: Work with suppliers who understand and adhere to pharmaceutical industry regulations.
  • Scalability: Choose a manufacturer capable of scaling up production to meet your commercial needs.

Engaging with experienced chemical suppliers in regions like China can provide access to competitive pricing and a stable supply chain for this important intermediate. Request a quote from reputable manufacturers to explore your purchasing options and ensure the quality required for your pharmaceutical synthesis needs.